Home Situations MRK — Strong businesses outperforming
Situation · 2026-04-24

MRK — Strong businesses outperforming

Discount Persists Despite Top-Tier Profitability

Updated 2026-04-10 · Ref: Drug Manufacturers - General
Key metrics — 2026-04-10
Peer score
63
Quality pct
62
Valuation pct
88
52w drawdown
-1.4%
21d vs sector
+10.7%
Peer group
Drug Manufacturers - General
Situation summary

Merck combines sector-leading profitability (ROIC 21.97%, margin 32.8%) with a steep valuation discount (forward P/E 12.2x). Core strengths in capital efficiency remain intact. However, weak revenue growth (5%) and a low growth score keep pressure on the stock. A rerating would require growth to match peers and proof that AI-driven R&D boosts the pipeline.

Published by AssetNext · 2026-04-20

All companies with this signal today

View full list: Strong businesses outperforming →

Related pages for MRK
Full peer analysis for Merck & Co., Inc. →Similar companies to MRKMRK peersAll MRK comparisonsS&P 500 context
Signal history — last 30 days
Date Signal Peer score Drawdown 21d vs sector
2026-04-10 Strong businesses outperforming 63 -1.4% +10.7%
2026-03-27 Strong businesses outperforming 62 -2.8% +10.5%

See MRK's full peer analysis

Break down MRK's structural position across all peer dimensions with the interactive app.

Open MRK in AssetNext →